Regulation of gene expression in vivo following transduction by two separate rAAV vectors
- PMID: 9702775
- DOI: 10.1038/nbt0898-757
Regulation of gene expression in vivo following transduction by two separate rAAV vectors
Abstract
Control of gene expression is important to gene therapy for purposes of both dosing and safety. In vivo regulation of gene expression was demonstrated following co-injection of two separate recombinant adeno-associated virus vectors, one encoding an inducible murine erythropoietin transgene and the other a transcriptional activator, directly into the skeletal muscle of adult immunocompetent mice. Transcription was controlled by systemic administration or withdrawal of tetracycline over an 18 week period, demonstrating that the two vectors were capable of transducing the same cell. Cellular or humoral immune responses against the transactivator protein were not detected.
Similar articles
-
Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.Gene Ther. 2007 Sep;14(17):1249-60. doi: 10.1038/sj.gt.3302984. Epub 2007 Jun 21. Gene Ther. 2007. PMID: 17581597
-
Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice.Gene Ther. 2006 Sep;13(17):1300-8. doi: 10.1038/sj.gt.3302766. Epub 2006 May 11. Gene Ther. 2006. PMID: 16688207
-
Inducible production of erythropoietin using intramuscular injection of block copolymer/DNA formulation.J Gene Med. 2005 Jan;7(1):80-6. doi: 10.1002/jgm.631. J Gene Med. 2005. PMID: 15468192
-
Immune responses to gene product of inducible promoters.Curr Gene Ther. 2007 Oct;7(5):334-46. doi: 10.2174/156652307782151461. Curr Gene Ther. 2007. PMID: 17979680 Review.
-
[Strategy for keeping efficient expression and pharmacodynamics in reducing rAAV gene medicine immune response based on the decrease of vector dosage].Yao Xue Xue Bao. 2013 Mar;48(3):305-14. Yao Xue Xue Bao. 2013. PMID: 23724640 Review. Chinese.
Cited by
-
Lack of humoral immune response to the tetracycline (Tet) activator in rats injected intracranially with Tet-off rAAV vectors.Gene Ther. 2010 May;17(5):616-25. doi: 10.1038/gt.2010.6. Epub 2010 Feb 18. Gene Ther. 2010. PMID: 20164859 Free PMC article.
-
Gene therapy for heart failure.Circ Res. 2012 Mar 2;110(5):777-93. doi: 10.1161/CIRCRESAHA.111.252981. Circ Res. 2012. PMID: 22383712 Free PMC article. Review.
-
In vivo gene regulation using tetracycline-regulatable systems.Adv Drug Deliv Rev. 2009 Jul 2;61(7-8):527-41. doi: 10.1016/j.addr.2008.12.016. Epub 2009 Apr 23. Adv Drug Deliv Rev. 2009. PMID: 19394373 Free PMC article. Review.
-
Current status of transcriptional regulation systems.Cytotechnology. 2006 Mar;50(1-3):109-19. doi: 10.1007/s10616-006-9007-6. Epub 2006 May 20. Cytotechnology. 2006. PMID: 19003074 Free PMC article.
-
Adeno-associated virus vectors and hematology.Blood. 1999 Aug 1;94(3):864-74. Blood. 1999. PMID: 10419876 Free PMC article. Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical